Delwedd Flaen

Modeling long-term persistence after 8 years of hepatitis B booster vaccination in 5- to 15-year-old children

Vaccination remains the most effective and cost-saving measure to protect against hepatitis B, a global health problem. It is crucial to characterize the persistence of the immune response after booster vaccination. This study aimed to quantify the persistence through mathematical modeling. Booster...

Disgrifiad llawn

Wedi'i Gadw mewn:

Manylion Llyfryddiaeth
Prif Awduron:	Yan Qiu (Awdur), Zi-Kang Wu (Awdur), Jie Wu (Awdur), Jun Yao (Awdur), Ying Liu (Awdur), Wen Ren (Awdur), Yu-Jing Sun (Awdur), Ling-Zhi Shen (Awdur), Jing-Jing Ren (Awdur)
Fformat:	Llyfr
Cyhoeddwyd:	Taylor & Francis Group, 2022-11-01T00:00:00Z.
Pynciau:	article
Mynediad Ar-lein:	Connect to this object online.
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg

Strategies for hepatitis B booster vaccination among children: an 8-year prospective cohort study
gan: Yan Qiu, et al.
Cyhoeddwyd: (2020)

Long-term persistence of anti-HBs after hepatitis B vaccination among adults: 8-year results
gan: Wen Ren, et al.
Cyhoeddwyd: (2020)

Long-term persistence of anti-HBs after hepatitis B vaccination among isolated anti-HBc positive adults in China: 8-years results
gan: Wen Ren, et al.
Cyhoeddwyd: (2021)

The effects of booster vaccination of hepatitis B vaccine on children 5-15 years after primary immunization: A 5-year follow-up study
gan: Zikang Wu, et al.
Cyhoeddwyd: (2018)

The effect of hepatitis B vaccination after five years on an entire population in an insular region of Southeast China
gan: Ying Liu, et al.
Cyhoeddwyd: (2021)

Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China
gan: Zhen-Zi Wang, et al.
Cyhoeddwyd: (2017)

Predictors of Booster Response to Hepatitis B Vaccine at 15 years of age: A Cross-Sectional School-Based Study
gan: Yu-Sheng Chen, et al.
Cyhoeddwyd: (2016)

Immunogenicity persistence of hepatitis A vaccines Healive® and Havrix® among children:15 years follow-up and long-term prediction
gan: Xiaoli Wang, et al.
Cyhoeddwyd: (2023)

Effects of hepatitis B vaccine boosters on anti-HBs-negative children after primary immunization
gan: Shunshun Lu, et al.
Cyhoeddwyd: (2017)

Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age
gan: Timo Vesikari, et al.
Cyhoeddwyd: (2020)

Persistence of antibody to 23-valent pneumococcal polysaccharide vaccine: a 5-year prospective follow-up cohort study
gan: Xiang Guo, et al.
Cyhoeddwyd: (2024)

Immune persistence and booster response of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) 5 years after primary vaccination of adults at ≥56 years of age
gan: Corwin A. Robertson, et al.
Cyhoeddwyd: (2024)

Prevalence and Trends of Sexual Behaviors Among Young Adolescents Aged 12 Years to 15 Years in Low and Middle-Income Countries: Population-Based Study
gan: Zhengyue Jing, et al.
Cyhoeddwyd: (2023)

Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction
gan: Yongji Wang, et al.
Cyhoeddwyd: (2020)

Persistence of immunity to hepatitis B vaccine as infants, 17 years earlier
gan: Zohreh Azarkar, et al.
Cyhoeddwyd: (2018)

Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults
gan: Xavier Sáez-Llorens, et al.
Cyhoeddwyd: (2018)

Long-term antibody persistence against hepatitis B in adolescents 14-15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy
gan: Tino F. Schwarz, et al.
Cyhoeddwyd: (2019)

Long-term protection at 20-31 years after primary vaccination with plasma-derived hepatitis B vaccine in a Chinese rural community
gan: Jing-Chen Ma, et al.
Cyhoeddwyd: (2020)

Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
gan: Weerawan Hattasingh, et al.
Cyhoeddwyd: (2022)

Hepatic adenoma in a 7-year-old girl: a case report and literature review
gan: Yan Gao, et al.
Cyhoeddwyd: (2023)

Bibliometric analysis of dendritic cell-based vaccines over the past 15 years
gan: Zhi Long, et al.
Cyhoeddwyd: (2024)

Persistence of Multimorbidity Among Women Aged 15-49 Years in India: An Analysis of Prevalence, Patterns and Correlation
gan: Babul Hossain, et al.
Cyhoeddwyd: (2021)

CP-25 exerts a protective effect against ConA-induced hepatitis via regulating inflammation and immune response
gan: Nan Li, et al.
Cyhoeddwyd: (2022)

Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration
gan: Shabir A. Madhi, et al.
Cyhoeddwyd: (2019)

Booster Vaksinasi Hepatitis B Terhadap Anak yang Non Responder
gan: Kusnandi Rusmil, et al.
Cyhoeddwyd: (2016)

Hepatitis B seroprotection in children aged 10-15 years after completion of basic hepatitis B immunizations
gan: Novie Homenta Rampengan, et al.
Cyhoeddwyd: (2017)

Strengthening the Key Features of Volumizing Fillers: Projection Capacity and Long-Term Persistence
gan: Killian Flégeau, et al.
Cyhoeddwyd: (2023)

Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: A further observation
gan: Yuemei Hu, et al.
Cyhoeddwyd: (2018)

Evidence for a 10-year TBE vaccine booster interval: an evaluation of current data
gan: Jörg Schelling, et al.
Cyhoeddwyd: (2024)

Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules
gan: Marco Costantini, et al.
Cyhoeddwyd: (2020)

Antibody persistence 7 years after hepatitis-A vaccine in children with human immunodeficiency virus infection
gan: José G. Vázquez-Rosales, et al.
Cyhoeddwyd: (2024)

The Effect of International Travel Arrivals on the New HIV Infections in 15-49 Years Aged Group Among 109 Countries or Territories From 2000 to 2018
gan: Min Du, et al.
Cyhoeddwyd: (2022)

Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy
gan: Xianbin Ma, et al.
Cyhoeddwyd: (2022)

Persistence and stability of sublingual varices over time and their connection to underlying factors: an 8 year follow up study
gan: Håkan Bergh, et al.
Cyhoeddwyd: (2022)

Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine
gan: Beatriz Quiambao, et al.
Cyhoeddwyd: (2020)

Vaginal Discharge that Persisted for 6 Years
gan: Siddharth Mani, et al.
Cyhoeddwyd: (2024)

Five-year antibody persistence in children after one dose of inactivated or live attenuated hepatitis A vaccine
gan: Zhilun Zhang, et al.
Cyhoeddwyd: (2017)

Maternal folic acid supplementation and antibody persistence 5 years after hepatitis B vaccination among infants
gan: Xinyu Zhao, et al.
Cyhoeddwyd: (2018)

Underreporting of the 5-year tetanus, diphtheria, pertussis and polio booster vaccination in the Danish Vaccination Register
gan: Sidsel Skou Voss, et al.
Cyhoeddwyd: (2020)

Suitable hepatitis B vaccine for adult immunization in China: a systematic review and meta-analysis
gan: Zikang Wu, et al.
Cyhoeddwyd: (2019)